Bio-Techne acquisition of ProteinSimple is a material positive, say Leerink Leerink views Bio-Techne's acquisition of ProteinSimple as a material positive as it will accelerate top-line growth and should be accretive in 2016 or sooner. The firm reiterates its Outperform rating and raised its price target to $98 from $93.
News For TECH From The Last 14 Days
Check below for free stories on TECH the last two weeks.
On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: Bio-Techne (TECH) initiated with an Overweight at Stephens... Culp (CFI) initiated with a Buy at Stifel... MobileIron (MOBL) initiated with an Outperform at Imperial Capital... NanoString (NSTG) management to meet with Piper Jaffray... SuperCom (SPCB) initiated with an Outperform at Imperial Capital.